Department of Medicine, Surgery and Neurosciences, University of Siena, Italy.
Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy.
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa252.
Paget disease of bone (PDB) is a metabolic bone disease whose genetic cause remains unknown in up to 50% of familial patients.
Our aim was to investigate the underlying genetic defect in a large pedigree with a severe, early onset, autosomal dominant form of PDB across 3 generations.
Whole exome sequencing was performed in affected and unaffected family members, and then mutation screening was replicated in a sample of PDB patients with early-onset, polyostotic PDB.
We identified a frameshift D107Rfs*3 mutation in PFN1 (encoding for profilin 1, a highly conserved regulator of actin-polymerization and cell motility) causing the truncation of the C-terminal part of the protein. The mutation was also detected in a 17-year-old asymptomatic family member who upon biochemical and radiological analyses was indeed found to be affected. Sequencing of the entire PFN1 coding region in unrelated PDB patients identified the same mutation in 1 patient. All mutation carriers had a reduced response to bisphosphonates, requiring multiple zoledronate infusions to control bone pain and achieve biochemical remission over a long term. In vitro osteoclastogenesis in peripheral blood mononuclear cells (PBMCs) from mutation carriers showed a higher number of osteoclasts with PDB-like features. A similar phenotype was observed upon PFN1 silencing in murine bone marrow-derived monocytes, suggesting that the frameshift PFN1 mutation confers a loss of function in profilin 1 activity that induces PDB-like features in the osteoclasts, likely due to enhanced cell motility and actin ring formation.
Our findings indicate that PFN1 mutation causes an early onset, polyostotic PDB-like disorder.
佩吉特骨病(Paget 骨病,PDB)是一种代谢性骨病,其遗传病因在多达 50%的家族性患者中仍然未知。
我们旨在研究一个大型家系中严重、早发性、常染色体显性遗传形式的 PDB 的潜在遗传缺陷,该家系跨越 3 代人。
对受影响和未受影响的家庭成员进行全外显子组测序,然后在患有早发性、多灶性 PDB 的 PDB 患者样本中进行突变筛查。
我们在 PFN1(编码原肌球蛋白 1,一种高度保守的肌动蛋白聚合和细胞运动调节剂)中发现了一个导致蛋白 C 端部分截断的错义 D107Rfs*3 突变。该突变也在一名 17 岁的无症状家族成员中被检测到,该成员在生化和放射学分析后确实被发现受到影响。对无关 PDB 患者的整个 PFN1 编码区进行测序,在 1 名患者中发现了相同的突变。所有突变携带者对双膦酸盐的反应降低,需要多次唑来膦酸盐输注来控制骨痛并在长期内实现生化缓解。来自突变携带者的外周血单核细胞(PBMCs)中的体外破骨细胞生成显示具有 PDB 样特征的破骨细胞数量增加。在鼠骨髓来源的单核细胞中沉默 PFN1 时也观察到类似的表型,这表明移码 PFN1 突变导致原肌球蛋白 1 活性丧失,从而在破骨细胞中诱导 PDB 样特征,可能是由于增强的细胞运动性和肌动蛋白环形成。
我们的研究结果表明,PFN1 突变导致早发性、多灶性 PDB 样疾病。